Erin Berry‐Bibee

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

Kathryn M. Curtis, Naomi K. Tepper, Tara C. Jatlaoui et al. · MMWR Recommendations and Reports · 2016 · 1.5K citations · Full text

Medicine, Gynecology, Obstetrics +15

The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016–17 Zika virus outbreak

Eva Lathrop, Lisa Romero, Stacey Hurst et al. · The Lancet Public Health · 2018 · 80 citations · Full text

Medicine, Community Health, Maternal Health +14

Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness — United States, 2011–2013 and 2015

Sheree L. Boulet, Denise V. D’Angelo, Brian Morrow et al. · MMWR Morbidity and Mortality Weekly Report · 2016 · 47 citations · Full text

Veterinary Medicine, Infectious Diseases, Maternal Health +17

Medication Abortion With Pharmacist Dispensing of Mifepristone

Daniel Grossman, C. Finley Baba, Shelly Kaller et al. · Obstetrics and Gynecology · 2021 · 40 citations · Full text

Medicine, Clinical Pharmacy, Pharmacy Practice +14

FDA Public Meeting Report on “Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications”

M. Rasyid Akbar, Erin Berry‐Bibee, Diana Blithe et al. · The Journal of Clinical Pharmacology · 2018 · 20 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17